Daphne Karydas, Director: Mineralys Therapeutics MLYS Planned sale · Filed 25/11/13

Trade details

Type: Planned sale notice
Stock: Mineralys Therapeutics MLYS
Person: Daphne KarydasDirector
Planned sale date: 25/11/13
Filed: 25/11/13

$689.8K to be sold

Mineralys Therapeutics trades, last 26 weeks

What else happened in Mineralys Therapeutics around then

Filed or reported within 30 days of the trade day · 25/10/14~25/12/13

Daphne Karydas's recent trades

Daphne KarydasDirector
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$85.7K
3,000 sh
$85.7K
Filed 09/15
Traded 09/15
Daphne KarydasDirector
Sell10b5-1 planMineralys Therapeutics
Sell10b5-1 plan
Mineralys Therapeutics
MLYS
$75K
3,000 sh
$75K
Filed 06/17
Traded 06/17
Daphne KarydasDirector
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$75K
3,000 sh
$75K
Filed 06/17
Traded 06/17
Daphne KarydasDirector
Sell10b5-1 planMineralys Therapeutics
Sell10b5-1 plan
Mineralys Therapeutics
MLYS
$75K
3,000 sh
$75K
Filed 04/02
Traded 03/31
Daphne KarydasDirector
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$75K
3,000 sh
$75K
Filed 03/31
Traded 03/31